Recombinant Hepatitis C Virus NS4 a+b
Produktgrößen
0.5 mg
£1030,00
32-5460-0.5MG
Über dieses Produkt
- SKU:
- 32-5460
- Weitere Details:
- Source : The E.coli derived 19 kDa recombinant protein contains the HCV NS4 immunodominant regions; amino acids 1658-1863. The protein is fused with b-galactosidase (114 kDa) at N-terminus; pI 5.45. HCV is a small 50nm; enveloped; single-stranded; positive sense RNAvirus in the family Flaviviridae. HCV has a high rate of replication with approximately one trillion particles produced each day in an infected individual. Due to lack of proofreading by the HCV RNA polymerase; the HCV has an exceptionally high mutation rate; a factor that may help it elude the host's immune response. Hepatitis C virus is classified into six genotypes(1-6) with several subtypes within each genotype. The preponderance and distribution of HCV genotypes varies globally. Genotype is clinically important in determining potential response to interferon-based therapy and the required duration of such therapy. Genotypes 1 and 4 are less responsive to interferon-based treatment than are the other genotypes (2; 3; 5 and 6).
- Aufreinigung:
- HCV NS4 a+b protein is >95% pure as determined by 10% PAGE (coomassie staining).
- Versandbedingungen:
- Blue Ice
- Lagerbedingungen:
- HCV NS4 a+b although stable at 4[o]C for 1 week; should be stored below -18[o]C. Please prevent freeze thaw cycles.
- Hersteller:
- Abeomics
- Typ:
- Proteins, Peptides, Small Molecules & Other Biomolecules:Recombinant Proteins
- Datenblatt des Herstellers:1.jpg